Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes

• Rebecca J. Hodge ,

  * E-mail: rhodge.dvm@gmail.com

  Affiliation Discovery Medicine, Metabolic Pathways Cardiovascular Unit, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Mark A. Paulik,

  Current address: Intarcia Therapeutics, Research Triangle Park, North Carolina, United States of America

  Affiliation Biology, Metabolic Pathways Cardiovascular Unit, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Ann Walker,

  Affiliation Quantitative Sciences - Clinical Statistics, R&D Projects Clinical Platforms and Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Joyce A. Boucheron,

  Affiliation Biology, Metabolic Pathways Cardiovascular Unit, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Susan L. McMullen,

  Current address: PAREXEL International, Durham, North Carolina, United States of America

  Affiliation Clinical Pharmacology Science and Study Operations, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Dawn S. Gillmor,

  Current address: PPD Inc., Morrisville, North Carolina, United States of America

  Affiliation Clinical Pharmacology Science and Study Operations, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Derek J. Nunez

  Affiliation Discovery Medicine, Metabolic Pathways Cardiovascular Unit, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯